These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 27349764)

  • 21. Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors.
    Mak V; Hamm J; Chhanabhai M; Shenkier T; Klasa R; Sehn LH; Villa D; Gascoyne RD; Connors JM; Savage KJ
    J Clin Oncol; 2013 Jun; 31(16):1970-6. PubMed ID: 23610113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter study.
    Reboursiere E; Le Bras F; Herbaux C; Gyan E; Clavert A; Morschhauser F; Malak S; Sibon D; Broussais F; Braun T; Fornecker LM; Garidi R; Tricot S; Houot R; Joly B; Abarah W; Choufi B; Pham AD; Gac AC; Fruchart C; Marin E; Safar V; Parcelier A; Maisonneuve H; Bachy E; Cartron G; Jaccard A; Tournilhac O; Rossi C; Schirmer L; Martignoles JA; Gaulard P; Tilly H; Damaj G;
    Oncotarget; 2016 Dec; 7(51):85573-85583. PubMed ID: 27458168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subcutaneous Panniculitis-Like T-Cell Lymphoma Versus Lupus Erythematosus Panniculitis: Distinction by Means of the Periadipocytic Cell Proliferation Index.
    Sitthinamsuwan P; Pattanaprichakul P; Treetipsatit J; Pongpruttipan T; Sukpanichnant S; Pincus LB; McCalmont TH
    Am J Dermatopathol; 2018 Aug; 40(8):567-574. PubMed ID: 29742552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum concentrations of l-kynurenine predict clinical outcomes of patients with peripheral T-cell lymphoma, not otherwise specified.
    Shibata Y; Hara T; Matsumoto T; Nakamura N; Nakamura H; Ninomiya S; Kitagawa J; Goto N; Nannya Y; Ito H; Kito Y; Miyazaki T; Takeuchi T; Saito K; Seishima M; Takami T; Moriwaki H; Shimizu M; Tsurumi H
    Hematol Oncol; 2017 Dec; 35(4):637-644. PubMed ID: 27338762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative analysis of extra-nodal NK/T-cell lymphoma and peripheral T-cell lymphoma: significant differences in clinical characteristics and prognosis.
    Lim ST; Hee SW; Quek R; Lim LC; Yap SP; Loong EL; Sng I; Tan LH; Ang MK; Ngeow J; Tham CK; Ngo L; Tan MH; Tao M
    Eur J Haematol; 2008 Jan; 80(1):55-60. PubMed ID: 18028433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High Level of Serum Soluble Interleukin-2 Receptor Is Associated With Poor Survival in Patients With First Relapsed or Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified: A Retrospective Study.
    Morita-Fujita M; Katoh D; Shimomura Y; Ishikawa T
    Clin Lymphoma Myeloma Leuk; 2019 Jul; 19(7):e337-e342. PubMed ID: 31053551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network.
    Federico M; Bellei M; Marcheselli L; Schwartz M; Manni M; Tarantino V; Pileri S; Ko YH; Cabrera ME; Horwitz S; Kim WS; Shustov A; Foss FM; Nagler A; Carson K; Pinter-Brown LC; Montoto S; Spina M; Feldman TA; Lechowicz MJ; Smith SM; Lansigan F; Gabus R; Vose JM; Advani RH;
    Br J Haematol; 2018 Jun; 181(6):760-769. PubMed ID: 29672827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unraveling subcutaneous panniculitis-like T-cell lymphoma: An association between subcutaneous panniculitis-like T-cell lymphoma, autoimmune lymphoproliferative syndrome, and familial hemophagocytic lymphohistiocytosis.
    LeBlanc RE; Lansigan F
    J Cutan Pathol; 2021 Apr; 48(4):572-577. PubMed ID: 32894575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival advantage with the addition of radiation therapy to chemotherapy in early stage peripheral T-cell lymphoma, not otherwise specified.
    Zhang XM; Li YX; Wang WH; Jin J; Wang SL; Liu YP; Song YW; Fang H; Ren H; Zhou LQ; Liu XF; Yu ZH
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1051-6. PubMed ID: 23021436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravascular large B-cell lymphoma in the United States (US): a population-based study using Surveillance, Epidemiology, and End Results program and National Cancer Database.
    Rajyaguru DJ; Bhaskar C; Borgert AJ; Smith A; Parsons B
    Leuk Lymphoma; 2017 Sep; 58(9):1-9. PubMed ID: 28278725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of prognostic scores in transplant-ineligible patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma: a retrospective study from the national hospital organization in Japan.
    Yamasaki S; Iida H; Yoshida I; Komeno T; Sawamura M; Matsumoto M; Sekiguchi N; Hishita T; Sunami K; Shimomura T; Takatsuki H; Yoshida S; Otsuka M; Kato T; Kuroda Y; Ooyama T; Suzuki Y; Ohshima K; Nagai H; Iwasaki H
    Leuk Lymphoma; 2021 Apr; 62(4):819-827. PubMed ID: 33167741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of primary organ site of involvement by peripheral T-cell lymphoma not otherwise specified on survival.
    Davis O; Truong D; Day S; Pandey M; Ibrahimi S; Khawandanah M; Holter-Chakrabarty J; Asch A; Al-Juhaishi T
    Cancer Med; 2023 Dec; 12(24):21770-21778. PubMed ID: 38073461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral T-cell lymphoma--not otherwise specified.
    Savage KJ; Ferreri AJ; Zinzani PL; Pileri SA
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):321-9. PubMed ID: 20702104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical significance of activated p-AKT expression in peripheral T-cell lymphoma.
    Hong JY; Hong ME; Choi MK; Chang W; Do IG; Jo JS; Jung SH; Park S; Kim SJ; Ko YH; Kim WS
    Anticancer Res; 2015 Apr; 35(4):2465-74. PubMed ID: 25862915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FoxP3-positive T cell lymphoma arising in non-HTLV1 carrier: clinicopathological analysis of 11 cases of PTCL-NOS and 2 cases of mycosis fungoides.
    Satou A; Asano N; Kato S; Katsuya H; Ishitsuka K; Elsayed AA; Nakamura S
    Histopathology; 2016 Jun; 68(7):1099-108. PubMed ID: 26426838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subcutaneous panniculitis-like T-cell lymphoma.
    Tomasini D; Berti E
    G Ital Dermatol Venereol; 2013 Aug; 148(4):395-411. PubMed ID: 23900161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fatal subcutaneous panniculitis-like T-cell lymphoma gamma/delta subtype (cutaneous gamma/delta T-cell lymphoma): report of a case and review of the literature.
    Kao GF; Resh B; McMahon C; Gojo I; Sun CC; Phillips D; Zhao XF
    Am J Dermatopathol; 2008 Dec; 30(6):593-9. PubMed ID: 19033937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hematopoietic stem cell transplantation for primary cutaneous γδ T-cell lymphoma and refractory subcutaneous panniculitis-like T-cell lymphoma.
    Gibson JF; Alpdogan O; Subtil A; Girardi M; Wilson LD; Roberts K; Foss F
    J Am Acad Dermatol; 2015 Jun; 72(6):1010-5.e5. PubMed ID: 25981001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome of combined modality treatment in first-line for stage I(E) peripheral T-cell lymphoma; a nationwide population-based cohort study from the Netherlands.
    Meeuwes FO; Brink M; Plattel W; Van der Poel MWM; Kersten MJ; Wondergem M; Böhmer L; Woei-A-Jin FJSH; Visser O; Oostvogels R; Jansen PM; Neelis KJ; Crijns APG; Daniëls LA; Snijders TJF; Vermaat JSP; Huls GA; Nijland M
    Haematologica; 2024 Apr; 109(4):1163-1170. PubMed ID: 37794805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of primary cutaneous γδ T-cell lymphoma and subcutaneous panniculitis-like T-cell lymphoma in the U.S.A. from 2006 to 2015: a Surveillance, Epidemiology, and End Results-18 analysis.
    Goyal A; Goyal K; Bohjanen K; Pearson D
    Br J Dermatol; 2019 Oct; 181(4):848-850. PubMed ID: 30951189
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.